SCHEMBL5572716

SCHEMBL5572716

Cc1cccc(Oc2ccc(O)c(C(C)(C)C)c2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESRRA P11474 6/20 0.51
▸ ALDH1A1 P00352 3/20 0.46
▸ GAA P10253 2/20 0.42
▸ POLB P06746 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ NR1I2 O75469 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ MIF P14174 1/20 0.41
▸ TYR P14679 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ NFE2L2 Q16236 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ NR1H4 Q96RI1 3/20 0.40
▸ ATM Q13315 2/20 0.40
▸ THRA P10827 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ HSD17B14 Q9BPX1 1/20 0.38
▸ PPARG P37231 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9008266 0.78 ESRRA (0.59) ESRRAALDH1A1GAAPOLBMAPT
SCHEMBL7204289 0.78 ESRRA (0.72) ESRRAALDH1A1GAAPOLBMAPT
SCHEMBL22009636 0.77 PPARG (0.40) ALDH1A1MAPTLMNACYP2C9HTT
SCHEMBL29716209 0.77 PPARG (0.40) ALDH1A1MAPTLMNACYP2C9HTT
SCHEMBL4597505 0.76 ESRRA (0.53) ESRRAALDH1A1GAAPOLBMAPT
SCHEMBL28519338 0.75 MEN1 (0.46) ALDH1A1MAPTLMNAHTTHSD17B10
SCHEMBL22061931 0.75 F10 (0.42) ALDH1A1MAPTHTTHSD17B10HSD17B14
Amelenodor SCHEMBL22061849 0.74 CCR1 (0.44) MAPTCYP2C9HTTATMPPARG
SCHEMBL4795858 0.73 F2 (0.40) MAPTLMNAHTTHSD17B14PPARG
SCHEMBL4795862 0.73 MAP4K4 (0.41) ALDH1A1POLBMAPTHTTPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070066624-A1 Chemokine receptor binding compounds ANORMED, INC. (CA) 2007-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066624-A1 Chemokine receptor binding compounds CCR5, CCR4, CCR1 ESRRA 689/4885ALDH1A1 3484/4885GAA 4340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback